View of Impact of Thyroid Hormone Receptor alpha Expression and PD-L1 on Progression-Free Survival of NSCLC Patients Treated with Pembrolizumab Immunotherapy

Return to Article Details Impact of Thyroid Hormone Receptor alpha Expression and PD-L1 on Progression-Free Survival of NSCLC Patients Treated with Pembrolizumab Immunotherapy Download Download PDF